New Science Ventures
New Science Ventures, LLC (NSV) is a venture capital firm specializing in building companies that leverage breakthrough science to create extraordinary value, focusing on the life sciences and information technology sectors.
2004
Privately held
Focuses on companies with high growth potential and distinct value propositions, indicating a preference for calculated risks with significant rewards.
Greenwich, Ct, United States
About
Mission
Creating value through breakthrough science.
Values
Emphasizing science-based innovation, robust intellectual property protection, and collaboration with the right investment teams.
Track Record
Notable Achievements
Successful exits such as Biovex (acquired by Amgen) and Conor Medsystems (acquired by Johnson & Johnson).
Project Track Record
Investments in companies like Novadip Biosciences, Sagence AI, and Ventyx Biosciences.
Get Full Profile
Access complete investment history, team details, portfolio companies, and direct contact information.
Unlock Full AccessHeadquarters
Greenwich, Ct, United States
Legal & Compliance
Compliant with anti-money laundering and data protection laws.
No major violations reported.
Access 150,000+ investor profiles
Get complete access to our database of investment firms with detailed profiles, contact information, investment preferences, and AI-powered matching.